Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mangoceuticals, Inc.

1.26
-0.2200-14.86%
Volume:804.26K
Turnover:1.01M
Market Cap:17.52M
PE:-0.40
High:1.39
Open:1.36
Low:1.18
Close:1.48
52wk High:6.15
52wk Low:0.9800
Shares:13.91M
Float Shares:7.55M
Volume Ratio:0.06
T/O Rate:10.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1399
EPS(LYR):-4.8401
ROE:-85.90%
ROA:-43.25%
PB:0.91
PE(LYR):-0.26

Loading ...

Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2024

Correspondence

Form CORRESP - Correspondence
May 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 23, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 23, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 19, 2023

Major Issues Report

Form 8-K - Current report